Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Physiol Res ; 69(1): 1-19, 2020 02 19.
Article in English | MEDLINE | ID: mdl-31852206

ABSTRACT

Multiple sclerosis (MS) is an autoimmune neurological disease characterized by chronic inflammation of the central nervous system (CNS), leading to demyelination and axonal damage and resulting in a range of physical, mental or even psychiatric symptoms. Key role of oxidative stress (OS) in the pathogenesis of MS has been suggested, as indicated by the biochemical analysis of cerebrospinal fluid and blood samples, tissue homogenates, and animal models of multiple sclerosis. OS causes demyelination and neurodegeneration directly, by oxidation of lipids, proteins and DNA but also indirectly, by inducing a dysregulation of the immunity and favoring the state of pro-inflammatory response. In this review, we discuss the interrelated mechanisms of the impaired redox signaling, of which the most important are inflammation-induced production of free radicals by activated immune cells and growth factors, release of iron from myelin sheath during demyelination and mitochondrial dysfunction and consequent energy failure and impaired oxidative phosphorylation. Review also provides an overview of the interplay between inflammation, immunity and OS in MS. Finally, this review also points out new potential targets in MS regarding attenuation of OS and inflammatory response in MS.


Subject(s)
Multiple Sclerosis/metabolism , Oxidation-Reduction , Animals , Antioxidants/metabolism , Antioxidants/therapeutic use , Humans , Inflammation/metabolism , Iron/metabolism , Mitochondria/metabolism , Multiple Sclerosis/immunology , Multiple Sclerosis/therapy , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...